Search details
1.
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN study.
Int J Cancer
; 153(1): 141-152, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36757197
2.
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.
Int J Cancer
; 153(6): 1227-1240, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37260368
3.
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
BMC Cancer
; 23(1): 543, 2023 Jun 13.
Article
in English
| MEDLINE | ID: mdl-37312086
4.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-34807464
5.
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
Eur J Haematol
; 108(2): 133-144, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34714555
6.
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial.
Int J Cancer
; 148(4): 950-960, 2021 02 15.
Article
in English
| MEDLINE | ID: mdl-32738823
7.
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer
; 148(7): 1685-1694, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33070307
8.
Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.
Support Care Cancer
; 29(11): 6633-6643, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-33956213
9.
Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer.
BMC Cancer
; 20(1): 286, 2020 Apr 06.
Article
in English
| MEDLINE | ID: mdl-32252684
10.
VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer.
Breast Cancer Res Treat
; 176(3): 637-647, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31115844
11.
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).
Eur J Haematol
; 102(2): 174-181, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30347466
12.
Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data.
Br J Sports Med
; 53(13): 812, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-30181323
13.
Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up.
Int J Cancer
; 142(6): 1148-1157, 2018 03 15.
Article
in English
| MEDLINE | ID: mdl-29082588
14.
Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).
Eur J Haematol
; 101(6): 766-773, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30091166
15.
Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy.
BMC Cancer
; 15: 186, 2015 Mar 27.
Article
in English
| MEDLINE | ID: mdl-25885634
16.
Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial.
BMC Cancer
; 14: 270, 2014 Apr 17.
Article
in English
| MEDLINE | ID: mdl-24742019
17.
Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy.
Acta Oncol
; 53(10): 1356-65, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24837860
18.
Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study.
BMC Cancer
; 13: 162, 2013 Mar 28.
Article
in English
| MEDLINE | ID: mdl-23537231
19.
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
J Bone Oncol
; 33: 100420, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35340302
20.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 38(12): 2191-2199, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36047998